Humberto Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Humberto Fernandes has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Vineeta Kaushik
Institute of Physical Chemistry, Polish Academy of Sciences, 01-224 Warsaw, Poland
4 shared publications Luca Gessa
International Centre for Translational Eye Research, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
2 shared publications- Luca Gessa
Integrated Structural Biology Group, International Centre for Translational Eye Research, Institute of Physical Chemistry, Polish Academy of Sciences
2 shared publications Michał Dąbrowski
Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
2 shared publicationsNelam Kumar
International Centre for Translational Eye Research, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
2 shared publications- Nelam Kumar
Integrated Structural Biology Group, International Centre for Translational Eye Research, Institute of Physical Chemistry, Polish Academy of Sciences
2 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (3) , 42
Old Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase
Aldose Reductase (AR; AKR1B1) is an enzyme that plays a key role in the metabolism of glucose and other carbonyl compounds, and whose hyperactivity contributes to oxidative stress and vascular dysfunction. Despite decades of investigation into this enzyme, inhibitors have failed to translate into clinical application for Diabetic Retinopathy (DR). We argue that these failures might arise from non-selective inhibition, considering the dual roles of AR, which contribute not only to DR pathology but also support retinal health, as AR is an important detoxifying enzyme for aldehydes produced during oxidative stress. Here, we discuss missing structural information, despite more than one hundred crystal structures of AR in complex with inhibitors. Our review bridges this gap by discussing how recent advances in structural biology, e.g., fragment-based drug discovery and MicroED, provide novel ways to selectively modulate AR functions, offering advantages for the detection of weak, allosteric, or conformation-dependent binding events. Despite past challenges, we suggest that therapeutic targeting of AR to find new-generation inhibitors will become more effective once we have a clearer understanding of the requirements for selective inhibition of AR, blocking its pathological impact while preserving its physiological functions. By integrating fragment screening and structural biology, we outline a strategy to reinvigorate AR modulation as a viable retina-specific approach for managing DR, with potentially broader relevance toward multiple diabetic microvascular complications.
- 27 February 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (3) , 42
Open AccessOld Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase
Aldose Reductase (AR; AKR1B1) is an enzyme that plays a key role in the metabolism of glucose and other carbonyl compounds, and whose hyperactivity contributes to oxidative stress and vascular dysfunction. Despite decades of investigation into this enzyme, inhibitors have failed to translate into clinical application for Diabetic Retinopathy (DR). We argue that these failures might arise from non-selective inhibition, considering the dual roles of AR, which contribute not only to DR pathology but also support retinal health, as AR is an important detoxifying enzyme for aldehydes produced during oxidative stress. Here, we discuss missing structural information, despite more than one hundred crystal structures of AR in complex with inhibitors. Our review bridges this gap by discussing how recent advances in structural biology, e.g., fragment-based drug discovery and MicroED, provide novel ways to selectively modulate AR functions, offering advantages for the detection of weak, allosteric, or conformation-dependent binding events. Despite past challenges, we suggest that therapeutic targeting of AR to find new-generation inhibitors will become more effective once we have a clearer understanding of the requirements for selective inhibition of AR, blocking its pathological impact while preserving its physiological functions. By integrating fragment screening and structural biology, we outline a strategy to reinvigorate AR modulation as a viable retina-specific approach for managing DR, with potentially broader relevance toward multiple diabetic microvascular complications.
- Open Access
- 16 December 2025
- Published by MDPI AG in Preprints.org
Old Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase
Despite decades of investigation, Aldose Reductase (AR; AKR1B1) -an enzyme that plays a key role in the metabolism of glucose and other carbonyl compounds and whose hy-peractivity contributes to oxidative stress and vascular dysfunction- inhibitors have failed to translate into clinical application for Diabetic Retinopathy (DR). We argue that these failures might arise from non-selective inhibition, which does not consider AR’s dual roles in pathology but also in retinal health, as AR is also an important detoxifying enzyme for aldehydes produced during oxidative stress, and discuss the missing structural infor-mation, despite the over one hundred crystal structures of AR in complex with inhibitors. Our review bridges this gap by proposing how recent advances in structural biology, namely, fragment-based drug discovery and MicroED, provide novel ways of selectively modulating AR functions, offering advantages in the detection of weak, allosteric, or conformation-dependent binding events. Despite past challenges, we suggest that therapeutic targeting or finding new-generation inhibitors for AR will become more effective once we have a clearer understanding of AR’s requirements for selective inhi-bition of its pathological and physiological functions. By integrating fragment screening and structural biology, we outline a strategy to reinvigorate AR modulation as a viable retina-specific approach for managing DR first, although potentially relevant across multiple diabetic microvascular complications later.
- 16 December 2025
- Published by MDPI AG in Preprints.org
Open AccessOld Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase
Despite decades of investigation, Aldose Reductase (AR; AKR1B1) -an enzyme that plays a key role in the metabolism of glucose and other carbonyl compounds and whose hy-peractivity contributes to oxidative stress and vascular dysfunction- inhibitors have failed to translate into clinical application for Diabetic Retinopathy (DR). We argue that these failures might arise from non-selective inhibition, which does not consider AR’s dual roles in pathology but also in retinal health, as AR is also an important detoxifying enzyme for aldehydes produced during oxidative stress, and discuss the missing structural infor-mation, despite the over one hundred crystal structures of AR in complex with inhibitors. Our review bridges this gap by proposing how recent advances in structural biology, namely, fragment-based drug discovery and MicroED, provide novel ways of selectively modulating AR functions, offering advantages in the detection of weak, allosteric, or conformation-dependent binding events. Despite past challenges, we suggest that therapeutic targeting or finding new-generation inhibitors for AR will become more effective once we have a clearer understanding of AR’s requirements for selective inhi-bition of its pathological and physiological functions. By integrating fragment screening and structural biology, we outline a strategy to reinvigorate AR modulation as a viable retina-specific approach for managing DR first, although potentially relevant across multiple diabetic microvascular complications later.
- Open Access
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1572630
Corrigendum: Two-photon excitation fluorescence in ophthalmology: safety and improved imaging for functional diagnostics
• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. In the published article, there was an error in the Funding statement. [The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The International Centre for Translational Eye Research (MAB/2019/12) project was carried out within the International Research Agendas programme of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund. VK was the awardee of the fellowship within PASIFIC postdoctoral fellowship programme (Agreement No PAN.BFB.S. BDN.315.022.2022
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1572630
Open AccessCorrigendum: Two-photon excitation fluorescence in ophthalmology: safety and improved imaging for functional diagnostics
• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. In the published article, there was an error in the Funding statement. [The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The International Centre for Translational Eye Research (MAB/2019/12) project was carried out within the International Research Agendas programme of the Foundation for Polish Science co-financed by the European Union under the European Regional Development Fund. VK was the awardee of the fellowship within PASIFIC postdoctoral fellowship programme (Agreement No PAN.BFB.S. BDN.315.022.2022
- Open Access
- 22 January 2025
- Published by The Royal Society in Open Biology
- Vol. 15 (1) , 240180
CryoEM structure and small-angle X-ray scattering analyses of porcine retinol-binding protein 3
The vertebrate visual cycle hinges on enzymatically converting all- trans -retinol (at-ROL) into 11- cis -retinal (11c-RAL), the chromophore that binds to opsins in photoreceptors, forming light-responsive pigments. When struck by a photon, these pigments activate the phototransduction pathway and initiate the process of vision. The enzymatic isomerization of at-ROL, crucial for restoring the visual pigments and preparing them to receive new light stimuli, relies on various enzymes found in both the photoreceptors and retinal pigment epithelium cells. To function effectively, retinoids must shuttle between these two cell types. Retinol-binding protein 3 (RBP3), located in the interphotoreceptor matrix, probably plays a pivotal role in this transport mechanism. Comprised of four retinoid-binding modules, RBP3 also binds fatty acids, potentially aiding retinal function by facilitating the loading and unloading of different retinoids at specific cell types thereby directing the cycle. In this study, we present a 3.67 Å cryoEM structure of porcine RBP3, along with molecular docking analysis and corroborative in-solution small-angle X-ray scattering data for titration of RBP3 with relevant ligands, that also give insights on RBP3 conformational adaptability.
- 22 January 2025
- Published by The Royal Society in Open Biology
- Vol. 15 (1) , 240180
Open AccessCryoEM structure and small-angle X-ray scattering analyses of porcine retinol-binding protein 3
The vertebrate visual cycle hinges on enzymatically converting all- trans -retinol (at-ROL) into 11- cis -retinal (11c-RAL), the chromophore that binds to opsins in photoreceptors, forming light-responsive pigments. When struck by a photon, these pigments activate the phototransduction pathway and initiate the process of vision. The enzymatic isomerization of at-ROL, crucial for restoring the visual pigments and preparing them to receive new light stimuli, relies on various enzymes found in both the photoreceptors and retinal pigment epithelium cells. To function effectively, retinoids must shuttle between these two cell types. Retinol-binding protein 3 (RBP3), located in the interphotoreceptor matrix, probably plays a pivotal role in this transport mechanism. Comprised of four retinoid-binding modules, RBP3 also binds fatty acids, potentially aiding retinal function by facilitating the loading and unloading of different retinoids at specific cell types thereby directing the cycle. In this study, we present a 3.67 Å cryoEM structure of porcine RBP3, along with molecular docking analysis and corroborative in-solution small-angle X-ray scattering data for titration of RBP3 with relevant ligands, that also give insights on RBP3 conformational adaptability.
- Open Access
- 3 January 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1293640
Two-photon excitation fluorescence in ophthalmology: safety and improved imaging for functional diagnostics
Two-photon excitation fluorescence (TPEF) is emerging as a powerful imaging technique with superior penetration power in scattering media, allowing for functional imaging of biological tissues at a subcellular level. TPEF is commonly used in cancer diagnostics, as it enables the direct observation of metabolism within living cells. The technique is now widely used in various medical fields, including ophthalmology. The eye is a complex and delicate organ with multiple layers of different cell types and tissues. Although this structure is ideal for visual perception, it generates aberrations in TPEF eye imaging. However, adaptive optics can now compensate for these aberrations, allowing for improved imaging of the eyes of animal models for human diseases. The eye is naturally built to filter out harmful wavelengths, but these wavelengths can be mimicked and thereby utilized in diagnostics via two-photon (2Ph) excitation. Recent advances in laser-source manufacturing have made it possible to minimize the exposure of in vivo measurements within safety, while achieving sufficient signals to detect for functional images, making TPEF a viable option for human application. This review explores recent advances in wavefront-distortion correction in animal models and the safety of use of TPEF on human subjects, both of which make TPEF a potentially powerful tool for ophthalmological diagnostics.
- 3 January 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1293640
Open AccessTwo-photon excitation fluorescence in ophthalmology: safety and improved imaging for functional diagnostics
Two-photon excitation fluorescence (TPEF) is emerging as a powerful imaging technique with superior penetration power in scattering media, allowing for functional imaging of biological tissues at a subcellular level. TPEF is commonly used in cancer diagnostics, as it enables the direct observation of metabolism within living cells. The technique is now widely used in various medical fields, including ophthalmology. The eye is a complex and delicate organ with multiple layers of different cell types and tissues. Although this structure is ideal for visual perception, it generates aberrations in TPEF eye imaging. However, adaptive optics can now compensate for these aberrations, allowing for improved imaging of the eyes of animal models for human diseases. The eye is naturally built to filter out harmful wavelengths, but these wavelengths can be mimicked and thereby utilized in diagnostics via two-photon (2Ph) excitation. Recent advances in laser-source manufacturing have made it possible to minimize the exposure of in vivo measurements within safety, while achieving sufficient signals to detect for functional images, making TPEF a viable option for human application. This review explores recent advances in wavefront-distortion correction in animal models and the safety of use of TPEF on human subjects, both of which make TPEF a potentially powerful tool for ophthalmological diagnostics.
- Open Access
Longitudinal conditional probability of symmetric DNA methylation in Arabidopsis plants
DNA replication in high eukaryotes requires the faithful transmission of both the sequence and its methylation status. DNA methyltransferases are not consistently reliable enzymes for accurately restoring methylation in newly synthesised DNA strands when working in isolation. In this study, we evaluated some of the factors that enhance the fidelity of DNA methyltransferases and measure their local and distant impacts on the neighbouring methylation status. A clear understanding of DNA methylation fidelity during replication is important for advances in epigenetic knowledge in general and the potential development of new diagnostics and therapies for epigenetic diseases. We used the Arabidopsis model system because it is moderately methylated, which is an important advantage over animal models since it reduces the chance of a fully-methylated symmetric methylation to virtually nil while providing sufficient occupancy to ensure reliable interpretations. In this study, we employed hairpin bisulfite and nanopore sequencing (1D and 1D 2 ) to test the inter- and intra-strand relationships among the neighbouring 5-methylcytosines (5mC) and evaluate the distribution of hemimethylated sites, as well as the correlations to other cues such as DNA methylation and histone marks. We observed that the presence of a CpG methylation site can predict the occurrence of neighbouring CpG methylation sites, but not necessarily CWG sites, whereas CWG methylation can predict both neighbouring CWG and CpG methylation locations. These predictabilities extend far beyond the size of a nucleosome, and sites 4 kb away still show higher probabilities of methylation compared to the global average. Graphic Graphic abstract Fidelity and longitudinal conditional methylation probability of CpG and CWG DNA methylation in Arabidopsis plants
Open AccessLongitudinal conditional probability of symmetric DNA methylation in Arabidopsis plants
DNA replication in high eukaryotes requires the faithful transmission of both the sequence and its methylation status. DNA methyltransferases are not consistently reliable enzymes for accurately restoring methylation in newly synthesised DNA strands when working in isolation. In this study, we evaluated some of the factors that enhance the fidelity of DNA methyltransferases and measure their local and distant impacts on the neighbouring methylation status. A clear understanding of DNA methylation fidelity during replication is important for advances in epigenetic knowledge in general and the potential development of new diagnostics and therapies for epigenetic diseases. We used the Arabidopsis model system because it is moderately methylated, which is an important advantage over animal models since it reduces the chance of a fully-methylated symmetric methylation to virtually nil while providing sufficient occupancy to ensure reliable interpretations. In this study, we employed hairpin bisulfite and nanopore sequencing (1D and 1D 2 ) to test the inter- and intra-strand relationships among the neighbouring 5-methylcytosines (5mC) and evaluate the distribution of hemimethylated sites, as well as the correlations to other cues such as DNA methylation and histone marks. We observed that the presence of a CpG methylation site can predict the occurrence of neighbouring CpG methylation sites, but not necessarily CWG sites, whereas CWG methylation can predict both neighbouring CWG and CpG methylation locations. These predictabilities extend far beyond the size of a nucleosome, and sites 4 kb away still show higher probabilities of methylation compared to the global average. Graphic Graphic abstract Fidelity and longitudinal conditional methylation probability of CpG and CWG DNA methylation in Arabidopsis plants
- Open Access
- 23 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4408
Towards a New Biomarker for Diabetic Retinopathy: Exploring RBP3 Structure and Retinoids Binding for Functional Imaging of Eyes In Vivo
Diabetic retinopathy (DR) is a severe disease with a growing number of afflicted patients, which places a heavy burden on society, both socially and financially. While there are treatments available, they are not always effective and are usually administered when the disease is already at a developed stage with visible clinical manifestation. However, homeostasis at a molecular level is disrupted before visible signs of the disease are evident. Thus, there has been a constant search for effective biomarkers that could signal the onset of DR. There is evidence that early detection and prompt disease control are effective in preventing or slowing DR progression. Here, we review some of the molecular changes that occur before clinical manifestations are observable. As a possible new biomarker, we focus on retinol binding protein 3 (RBP3). We argue that it displays unique features that make it a very good biomarker for non-invasive, early-stage DR detection. Linking chemistry to biological function and focusing on new developments in eye imaging and two-photon technology, we describe a new potential diagnostic tool that would allow rapid and effective quantification of RBP3 in the retina. Moreover, this tool would also be useful in the future to monitor therapeutic effectiveness if levels of RBP3 are elevated by DR treatments.
- 23 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4408
Open AccessTowards a New Biomarker for Diabetic Retinopathy: Exploring RBP3 Structure and Retinoids Binding for Functional Imaging of Eyes In Vivo
Diabetic retinopathy (DR) is a severe disease with a growing number of afflicted patients, which places a heavy burden on society, both socially and financially. While there are treatments available, they are not always effective and are usually administered when the disease is already at a developed stage with visible clinical manifestation. However, homeostasis at a molecular level is disrupted before visible signs of the disease are evident. Thus, there has been a constant search for effective biomarkers that could signal the onset of DR. There is evidence that early detection and prompt disease control are effective in preventing or slowing DR progression. Here, we review some of the molecular changes that occur before clinical manifestations are observable. As a possible new biomarker, we focus on retinol binding protein 3 (RBP3). We argue that it displays unique features that make it a very good biomarker for non-invasive, early-stage DR detection. Linking chemistry to biological function and focusing on new developments in eye imaging and two-photon technology, we describe a new potential diagnostic tool that would allow rapid and effective quantification of RBP3 in the retina. Moreover, this tool would also be useful in the future to monitor therapeutic effectiveness if levels of RBP3 are elevated by DR treatments.
- 1 July 2021
- Published by Canadian Science Publishing in Genome
- Vol. 64 (7) , 693-704
In-vitro anti-fungal assay and association analysis reveal a role for the Pinus monticola PR10 gene (PmPR10-3.1) in quantitative disease resistance to white pine blister rust
Pathogenesis-related (PR) proteins play important roles in plant defense response. However, functional investigation of PR10 genes is still limited and their physiological roles have not been conclusively characterized in biological processes of conifer trees. Here, we identified multiple novel members in the western white pine (Pinus monticola) PmPR10 family by bioinformatic mining available transcriptomic data. Phylogenetic analysis of protein sequences revealed four PR10 and two PR10-like clusters with a high synteny across different species of five-needle pines. Of 10 PmPR10 genes, PmPR10-3.1 was selected and expressed in Escherichia coli. The purified recombinant protein exhibited inhibitory effects on spore hyphal growth of fungal pathogens Cronartium ribicola, Phoma exigua, and Phoma argillacea by in-vitro anti-fungal analysis. Genetic variation analysis detected a total of 21 single nucleotide polymorphisms (SNPs) within PmPR10-3.1 in a collection of P. monticola seed families. A nonsynonymous SNP (t178g) showed significant association with relative levels of quantitative disease resistance (QDR), explaining about 8.7% of phenotypic variation as the peak value across all SNPs. Our results provide valuable insight into the genetic architecture underlying P. monticola QDR and imply that PmPR10-3.1 may function as an important component in conifer basal immunity for non-specific resistance to a wide spectrum of pathogens.
- 1 July 2021
- Published by Canadian Science Publishing in Genome
- Vol. 64 (7) , 693-704
In-vitro anti-fungal assay and association analysis reveal a role for the Pinus monticola PR10 gene (PmPR10-3.1) in quantitative disease resistance to white pine blister rust
Pathogenesis-related (PR) proteins play important roles in plant defense response. However, functional investigation of PR10 genes is still limited and their physiological roles have not been conclusively characterized in biological processes of conifer trees. Here, we identified multiple novel members in the western white pine (Pinus monticola) PmPR10 family by bioinformatic mining available transcriptomic data. Phylogenetic analysis of protein sequences revealed four PR10 and two PR10-like clusters with a high synteny across different species of five-needle pines. Of 10 PmPR10 genes, PmPR10-3.1 was selected and expressed in Escherichia coli. The purified recombinant protein exhibited inhibitory effects on spore hyphal growth of fungal pathogens Cronartium ribicola, Phoma exigua, and Phoma argillacea by in-vitro anti-fungal analysis. Genetic variation analysis detected a total of 21 single nucleotide polymorphisms (SNPs) within PmPR10-3.1 in a collection of P. monticola seed families. A nonsynonymous SNP (t178g) showed significant association with relative levels of quantitative disease resistance (QDR), explaining about 8.7% of phenotypic variation as the peak value across all SNPs. Our results provide valuable insight into the genetic architecture underlying P. monticola QDR and imply that PmPR10-3.1 may function as an important component in conifer basal immunity for non-specific resistance to a wide spectrum of pathogens.
- Open Access
DNA adenine methylation in eukaryotes: Enzymatic mark or a form of DNA damage?
6‐methyladenine (6mA) is fairly abundant in nuclear DNA of basal fungi, ciliates and green algae. In these organisms, 6mA is maintained near transcription start sites in ApT context by a parental‐strand instruction dependent maintenance methyltransferase and is positively associated with transcription. In animals and plants, 6mA levels are high only in organellar DNA. The 6mA levels in nuclear DNA are very low. They are attributable to nucleotide salvage and the activity of otherwise mitochondrial METTL4, and may be considered as a price that cells pay for adenine methylation in RNA and/or organellar DNA. Cells minimize this price by sanitizing dNTP pools to limit 6mA incorporation, and by converting 6mA that has been incorporated into DNA back to adenine. Hence, 6mA in nuclear DNA should be described as an epigenetic mark only in basal fungi, ciliates and green algae, but not in animals and plants.
Open AccessDNA adenine methylation in eukaryotes: Enzymatic mark or a form of DNA damage?
6‐methyladenine (6mA) is fairly abundant in nuclear DNA of basal fungi, ciliates and green algae. In these organisms, 6mA is maintained near transcription start sites in ApT context by a parental‐strand instruction dependent maintenance methyltransferase and is positively associated with transcription. In animals and plants, 6mA levels are high only in organellar DNA. The 6mA levels in nuclear DNA are very low. They are attributable to nucleotide salvage and the activity of otherwise mitochondrial METTL4, and may be considered as a price that cells pay for adenine methylation in RNA and/or organellar DNA. Cells minimize this price by sanitizing dNTP pools to limit 6mA incorporation, and by converting 6mA that has been incorporated into DNA back to adenine. Hence, 6mA in nuclear DNA should be described as an epigenetic mark only in basal fungi, ciliates and green algae, but not in animals and plants.
- Open Access
Crystal structure of human Acinus RNA recognition motif domain
Acinus is an abundant nuclear protein involved in apoptosis and splicing. It has been implicated in inducing apoptotic chromatin condensation and DNA fragmentation during programmed cell death. Acinus undergoes activation by proteolytic cleavage that produces a truncated p17 form that comprises only the RNA recognition motif (RRM) domain. We have determined the crystal structure of the human Acinus RRM domain (AcRRM) at 1.65 Å resolution. It shows a classical four-stranded antiparallel β-sheet fold with two flanking α-helices and an additional, non-classical α-helix at the C-terminus, which harbors the caspase-3 target sequence that is cleaved during Acinus activation. In the structure, the C-terminal α-helix partially occludes the potential ligand binding surface of the β-sheet and hypothetically shields it from non-sequence specific interactions with RNA. Based on the comparison with other RRM-RNA complex structures, it is likely that the C-terminal α-helix changes its conformation with respect to the RRM core in order to enable RNA binding by Acinus.
Open AccessCrystal structure of human Acinus RNA recognition motif domain
Acinus is an abundant nuclear protein involved in apoptosis and splicing. It has been implicated in inducing apoptotic chromatin condensation and DNA fragmentation during programmed cell death. Acinus undergoes activation by proteolytic cleavage that produces a truncated p17 form that comprises only the RNA recognition motif (RRM) domain. We have determined the crystal structure of the human Acinus RRM domain (AcRRM) at 1.65 Å resolution. It shows a classical four-stranded antiparallel β-sheet fold with two flanking α-helices and an additional, non-classical α-helix at the C-terminus, which harbors the caspase-3 target sequence that is cleaved during Acinus activation. In the structure, the C-terminal α-helix partially occludes the potential ligand binding surface of the β-sheet and hypothetically shields it from non-sequence specific interactions with RNA. Based on the comparison with other RRM-RNA complex structures, it is likely that the C-terminal α-helix changes its conformation with respect to the RRM core in order to enable RNA binding by Acinus.